MDXG Competitors & Alternatives
Compare MiMedx Group Inc with similar stocks in the same industry
Biotechnology
MDXG
Main Stock$4.33
Tradestie Score
51
Market Cap
$1.01B
P/E Ratio
107.5
Revenue Growth
-0.3%
Analyst Upside
+61.7%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$142.04
|
$699.30M | - | 40 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.91
|
$688.47M | - | 38 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
ARVN
Arvinas, Inc
|
$9.37
|
$670.30M | 37.6 | 41 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$14.34
|
$665.30M | 17.3 | 34 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$17.63
|
$626.91M | - | 57 | Compare |
|
SVRA
Savara Inc.
|
$5.59
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.28
|
$552.46M | - | 47 | Compare |
More MDXG Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 3841)
239 stocks in this industry